Nov 3 (Reuters) - Laboratory Corp of America Holdings , a provider of healthcare diagnostic services, said it would buy contract research company Covance Inc for about $6.1 billion in cash and stock.
Covance shareholders will receive $75.76 in cash and 0.2686 LabCorp shares for each share held.
The offer of $105.12 per share, based on LabCorp's Friday closing price, represents a premium of 32 percent. (Reporting by Natalie Grover in Bangalore; Editing by Sriraj Kalluvila)
Covance shareholders will receive $75.76 in cash and 0.2686 LabCorp shares for each share held.
The offer of $105.12 per share, based on LabCorp's Friday closing price, represents a premium of 32 percent. (Reporting by Natalie Grover in Bangalore; Editing by Sriraj Kalluvila)
via Smart Health Shop Forum http://ift.tt/1o9Jble
No comments:
Post a Comment